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AMPK is a kinase involved in cell energy homeostasis. In this issue of Cell Metabolism, Chopra and
colleagues (2011) reveal a new function of AMPK in stimulating fat absorption. AMPK enhances the
expression of the bile acid transporter, BSEP, by activating the coactivator SRC-2, thus promoting bile
acid secretion.Energy regulation is an essential process
in all organisms. It is necessary to pre-
serve a constant ATP concentration for
metabolic processes at the cellular level
and to maintain a balance between
energy supply and energy expenditure
when considering the whole organism.
AMP-activated protein kinase (AMPK) is
considered one of the major regulators
of cellular and whole-body energy
homeostasis. AMPK activation requires
the phosphorylation of its a subunit at
Thr172 by upstream kinases: LKB1 (liver
kinase B1), the main upstream kinase
active in the liver, and Ca2+/calmodulin-
dependent protein kinase kinase. It is
activated by various stresses that in-
crease the cellular AMP/ATP ratio, and
its main role is to restore energy homeo-
stasis by slowing down ATP-consuming
pathways (e.g., fatty acid synthesis and
gluconeogenesis) and activating sub-
strate provision such as glucose transport
in muscles and ATP-producing pathways
(fatty acid oxidation). AMPK is also
involved in whole-body homeostasis,
since it integrates many hormonal and
adipokine signals (leptin, ghrelin, adipo-
nectin) involved in the central stimulation
of food intake (Kahn et al., 2005).
In this issue, O’Malley and colleagues
discover a novel function of AMPK in the
control of fat absorption (Chopra et al.,
2011). They found that hepatic invalida-
tion of the transcriptional coactivator
SRC-2 (steroid receptor coactivator-2) in
mice is concomitant with a reduced
capacity to absorb triglycerides from
the gut lumen into the enterocytes. This
results in an increased fecal content of
triglycerides and decreased plasmatriglyceride concentration. Since bile
acids (BAs) are necessary for dietary lipid
absorption, the authors explored a
possible deficiency in BA secretion in
hepatic SRC-2 knockout (KO) mice. The
SRC-2 KOmice display increased hepatic
BA concentrations and decreased biliary
BA levels, consistent with a defect in
hepatic BA secretion into the gut.
Interestingly, the fat malabsorption is
completely rescued in SRC-2 KO mice
receiving exogenous BAs in their diet,
suggesting that SRC-2 regulates BA
secretion from the liver to the intestine.
Analysis of BA hepatic transporters
revealed a defect in BSEP (bile salt export
pump) expression in the liver of SRC-2
KOmice. Accordingly, adenoviral overex-
pression of BSEP was sufficient to
completely reverse triglyceride malab-
sorption. BSEP expression is controlled
by the farnesoid X receptor (FXR) (Anan-
thanarayananet al., 2001), and theauthors
found that SRC-2 synergized with FXR for
BSEP promoter activation. Interestingly,
the other members of the p160 family
of coactivators, SRC-1 and SRC-3, do
not interact with the BSEP promoter,
confirmed by appropriate BA regulation
observed in SRC-1 and SRC-3 KO mice.
The authors then hypothesized that since
SRC-2 promotes energy intake (increase
of fat absorption), this coactivator could
itself be regulated by changes in energy
status. Indeed, AMPK phosphorylates
purified SRC-2 in an AMP-dependent
manner, and AMPK activation increased
the transcriptional activity of SRC-2.
Moreover, both SRC-2 and FXR are re-
quired to transmit the AMPK effect to
the BSEP promoter. Consequently, BSEPCell Metabolismexpression is strongly induced when
AMPK is activated. In addition, BSEP
expression is decreased and the hepatic
BA content is (modestly) increased in the
livers of AMPKa1/a2 double KO mice.
In summary, O’Malley and colleagues
demonstrate that SRC-2 promotes BA
secretion and thus lipid absorption by
controlling the expression of the canalic-
ular transporter BSEP. Furthermore, they
show that AMPK stimulates the expres-
sion of BSEP through SRC-2 activation
(Chopra et al., 2011).
Two other recent papers support a role
for AMPK in BA metabolism. Fu and
colleagues demonstrated that inhibition
of the LKB1-AMPK pathway strongly
impaired canalicular network formation
in rat cultured hepatocytes (Fu et al.,
2010), while Woods et al. (2010) used
liver-specific LKB1 KO mice to show
that LKB1 is necessary for biliary tree
and canalicular formation and BA homeo-
stasis. Liver-specific deletion of LKB1
causes a mislocalization of BSEP, from
the canalicular membrane to a cyto-
plasmic localization, resulting in toxic
accumulation of BAs in the liver (Woods
et al., 2010). In this later study, and in
contrast with the work of O’Malley et al.,
BSEP expression is not altered, although
AMPK activity is strongly downregulated.
Interestingly, in AMPKa1/a2 double KO
mice, the expression of BSEP is also
only modestly altered. These studies
suggest that AMPK activation could regu-
late BSEP at both transcriptional and
posttranslational levels in conditions of
energy depletion.
This work of Chopra et al. (2011) sheds
light on a new role of SRC-2 and AMPK13, January 5, 2011 ª2011 Elsevier Inc. 1
Figure 1. Role of AMPK in Lipid Metabolism
AMP-activated protein kinase (AMPK) is considered a major regulator of cellular and whole-body energy homeostasis. AMPK is involved in the control of whole-
body homeostasis by regulating food intake. In the liver and skeletal muscles, AMPK activates ATP-producing pathways such as fatty acid oxidation. In this
paper, by studying hepatic SRC-2 KO mice, Chopra et al., (2011) revealed a new function of AMPK in the control of triglyceride absorption. They identified
the p160 family member SRC-2 as a new AMPK target protein. SRC-2 phosphorylation by AMPK promotes, in coordination with the FXR nuclear receptor,
the transactivation of the BSEP (bile salt export pump) promoter, leading to secretion of BAs into the gut lumen, thus facilitating lipid absorption. AMPK is
thus involved in all aspects of lipid metabolism (pathways stimulated by AMPK are labeled with red text).
Cell Metabolism
Previewsin the control of lipid availability and
raises numerous questions. In addition
to decreased BSEP expression, SRC-2
KO mice presented a decreased expres-
sion of other BA transporters, such as
OSTb, MRP2, and cholesterol trans-
porters ABCG5 and ABCG8 (the last three
being members of the ABC transporter
family) (Chopra et al., 2011). It would be
interesting to study whether AMPK also
controls the expression of these trans-
porters, although this might seem para-
doxical since most of these transporters
are of the ABC family and are consuming
ATP to fulfill their role.
Chopra et al. (2011) showed that
besides SRC-2, AMPK activation in-
creased the transcriptional activity of
the other p160 members, SRC-1 and
SRC-3. Since BSEP promoter is not
a target of SRC-1 and SRC-3, the func-
tional consequences of their activation
by AMPK remain to be determined. Since
AMPK is shown here to be involved indi-
rectly in energy absorption, studying the
role of AMPK in both glucose and lipid
absorption in the intestine is also certainly2 Cell Metabolism 13, January 5, 2011 ª2011worthwhile. For instance, some studies
have shown that AMPK activation in-
creases the localization of the glucose
transporter GLUT2 on the apical mem-
brane of enterocytes (Walker et al.,
2005; Sakar et al., 2010). This suggests
that AMPK could also promote glucose
absorption in the intestine. As mentioned
previously, whereas the LKB1 KO mice
present a severe phenotype of chole-
stasis, the AMPK double KO mice
described (Chopra et al., 2011) have only
modest modifications of hepatic and
serum BA concentrations. Since LKB1
controls the activity of a family of 13
kinases, including AMPK (Lizcano et al.,
2004), this suggests that other kinases of
this family could also be involved in BA
metabolism.
AMPK was known to activate food
intake (and thus lipid provision) and tissue
fat oxidation. Chopra et al. (2011), by
showing that AMPK also activates intes-
tinal lipid absorption, demonstrate that
AMPK is involved in all steps of lipid
metabolism, allowing efficient increase
of cellular energy provision (Figure 1).Elsevier Inc.REFERENCES
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